TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC PEN NEEDLES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 ASIA-PACIFIC PEN NEEDLES MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 MULTIVARIATE MODELING
2.8 PRODUCTS LIFELINE CURVE
2.9 VENDOR SHARE ANALYSIS
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING PREVALENCE OF DIABETES
3.1.2 INCREASING GERIATRIC POPULATION
3.1.3 RISING GOVERNMENT INITIATIVES
3.2 RESTRAINT
3.2.1 PREFERENCE FOR ALTERNATIVE MODES OF DRUG DELIVERY
3.3 OPPORTUNITIES
3.3.1 RISE IN AWARENESS AMONG THE POPULATION
3.3.2 INCREASING BIOSIMILAR DRUG AVAILABILITY
3.4 CHALLENGES
3.4.1 REUSE OF PEN NEEDLES
3.4.2 STRICT REGULATORY REQUIREMENTS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 ASIA-PACIFIC PEN NEEDLES MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 STANDARD PEN NEEDLES
6.3 SAFETY PEN NEEDLES
7 ASIA-PACIFIC PEN NEEDLES MARKET, BY PRODUCT LENGTH
7.1 OVERVIEW
7.2 MEDIUM LENGTH
7.3 NANO LENGTH
7.4 LONG LENGTH
8 ASIA-PACIFIC PEN NEEDLES MARKET, BY USABILITY
8.1 OVERVIEW
8.2 REUSABLE
8.3 DISPOSABLE
9 ASIA-PACIFIC PEN NEEDLES MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DIABETES
9.3 GROWTH HORMONE DEFICIENCY
9.4 OTHERS
10 ASIA-PACIFIC PEN NEEDLES MARKET, BY THERAPY
10.1 OVERVIEW
10.2 INSULIN
10.3 GLUCAGON-LIKE PEPTIDE-1
10.4 GROWTH HORMONES
10.5 OTHERS
11 ASIA-PACIFIC PEN NEEDLES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOME HEALTHCARE
11.3 HOSPITALS
11.4 CLINICS
11.5 OTHERS
?
12 ASIA-PACIFIC PEN NEEDLES MARKET, BY GEOGRAPHY
12.1 ASIA-PACIFIC
12.1.1 CHINA
12.1.2 JAPAN
12.1.3 INDIA
12.1.4 SOUTH KOREA
12.1.5 AUSTRALIA
12.1.6 MALAYSIA
12.1.7 SINGAPORE
12.1.8 THAILAND
12.1.9 INDONESIA
12.1.10 PHILIPPINES
12.1.11 REST OF ASIA-PACIFIC
13 ASIA-PACIFIC PEN NEEDLES MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 COMPANY PROFILE
14.1 NOVO NORDISK A/S
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 SANOFI
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 ELI LILLY AND COMPANY
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
?
14.4 BD
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 A. MENARINI DIAGNOSTICS SRL
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 ALLISON MEDICAL, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 B. BRAUN MELSUNGEN AG
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 DIGITAL MEDICS PTY LTD
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 DOMREX PHARMA INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.10 FACET MEDICAL TECHNOLOGIES
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 HTL- STREFA S.A.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 KD MEDICAL GMBH HOSPITAL PRODUCTS
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
?
14.13 LDI LTD., LLC
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.14 MEDEXEL CO., LTD.
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 OWEN MUMFORD LTD
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 PENDIQ GMBH
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 STAT MEDICAL DEVICES.
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 TERUMO CORPORATION
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 VOGT MEDICAL
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.20 WILHELM HASELMEIER GMBH & CO. KG
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENTS
14.21 YPSOMED AG
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
?
15 QUESTIONNAIRE
16 RELATED REPORTS